NCT03506373 2026-03-05Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom MacroglobulinemiaMayo ClinicPhase 2 Terminated21 enrolled 11 charts
NCT01198067 2025-09-04Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom MacroglobulinemiaM.D. Anderson Cancer CenterPhase 1 Terminated15 enrolled 12 charts
NCT03333486 2025-07-04Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerRoswell Park Cancer InstitutePhase 2 Terminated31 enrolled 18 charts
NCT03246906 2025-06-04Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationFred Hutchinson Cancer CenterPhase 2 Terminated150 enrolled